Cipla

₹1515.7 10.4 | 0.7%

WEBSITE BSE:500087 NSE : CIPLA LTD. 01 Jul, 15:59

Market Cap ₹122431 Cr.

Stock P/E 23.1

P/B 3.9

Current Price ₹1515.7

Book Value ₹ 384.8

Face Value 2

52W High ₹1702

Dividend Yield 1.06%

52W Low ₹ 1310.1

Edit Ratio

Cipla Research see more...

Overview Inc. Year: 1935Industry: Pharmaceuticals & Drugs

Cipla Limited is an primarily India-based enterprise, usually engaged in the commercial enterprise of pharmaceuticals. The Company's segments consist of Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in growing, manufacturing, promoting and distributing widespread or branded accepted medicines, in addition to Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a customer healthcare, Biosimilars and distinctiveness enterprise. Its product portfolio spans complex generics, as well as drugs within the breathing, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, America, South Africa and Rest of the World. The Company has its community of manufacturing, buying and selling and different incidental operations in India and International markets. The Company has total of 46 manufacturing sites.

Cipla Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Cipla Quarterly Results

#(Fig in Cr.)	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Sales	5810	5739	6329	6678	6604	6163	6694	7051	7073	6730
Other Income	114	135	136	176	185	249	160	191	222	289
Total Income	5925	5874	6465	6854	6788	6413	6854	7242	7295	7019
Total Expenditure	4403	4566	4835	4944	4856	4847	4978	5165	5084	5192
Operating Profit	1522	1308	1630	1910	1932	1565	1876	2076	2211	1827
Interest	32	34	16	26	30	18	18	15	15	14
Depreciation	272	346	239	290	233	288	247	272	280	309
Exceptional Income / Expenses	0	-182	0	0	-195	0	0	0	0	0
Profit Before Tax	1218	745	1375	1594	1474	1259	1611	1789	1916	1504
Provision for Tax	410	222	378	438	405	325	435	483	332	279
Profit After Tax	808	523	997	1156	1069	934	1176	1306	1584	1225
Adjustments	-7	3	-1	-25	-13	5	1	-3	-13	-3
Profit After Adjustments	801	526	996	1131	1056	939	1178	1303	1571	1222
Adjusted Earnings Per Share	9.9	6.5	12.3	14	13.1	11.6	14.6	16.1	19.4	15.1

Cipla Profit & Loss

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Net Sales	11345	13595	14394	15156	16362	17132	19160	21763	22753	25774	27548	27548
Other Income	166	208	229	358	477	369	270	322	512	747	862	862
Total Income	11511	13803	14623	15513	16839	17501	19429	22085	23265	26521	28409	28410
Total Expenditure	9184	11115	11919	12329	13265	13951	14911	17251	17763	19483	20420	20419
Operating Profit	2327	2688	2704	3184	3574	3550	4518	4834	5502	7038	7990	7990
Interest	168	207	159	114	168	197	161	106	110	90	62	62
Depreciation	505	754	1323	1323	1326	1175	1068	1052	1172	1051	1107	1108
Exceptional Income / Expenses	0	0	0	-78	0	0	0	-182	-182	-195	0	0
Profit Before Tax	1654	1727	1222	1669	2079	2178	3290	3493	4038	5702	6821	6820
Provision for Tax	400	332	180	250	570	631	889	934	1203	1547	1530	1529
Profit After Tax	1254	1395	1042	1419	1510	1547	2401	2559	2835	4155	5291	5291
Adjustments	-73	-35	-36	-9	18	-0	4	-43	-34	-34	-19	-18
Profit After Adjustments	1181	1360	1006	1411	1528	1547	2405	2517	2802	4122	5273	5274
Adjusted Earnings Per Share	14.7	16.9	12.5	17.5	19	19.2	29.8	31.2	34.7	51.1	65.3	65.2

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	7%	8%	10%	9%
Operating Profit CAGR	14%	18%	18%	13%
PAT CAGR	27%	27%	28%	15%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	2%	17%	19%	9%
ROE Average	18%	16%	15%	13%
ROCE Average	24%	22%	20%	16%

Cipla Balance Sheet

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Shareholder's Funds	10801	11516	12544	14229	15012	15763	18327	20842	23408	26706	31193
Minority's Interest	180	350	438	352	332	294	259	276	306	96	96
Borrowings	309	222	3645	3662	3830	2369	1203	416	0	0	12
Other Non-Current Liabilities	2108	1185	868	597	816	603	457	205	184	82	-43
Total Current Liabilities	3881	7776	3374	3832	3772	4393	4591	4913	5033	5246	5484
Total Liabilities	17281	21049	20869	22673	23762	23423	24837	26652	29007	32130	36742
Fixed Assets	6830	9368	9490	9949	9547	9559	9394	9622	9101	9494	9895
Other Non-Current Assets	2860	2840	2574	1910	1789	2158	2234	2303	2631	3195	3559
Total Current Assets	7591	8841	8736	10814	12425	11704	13181	14711	16805	19392	23249
Total Assets	17281	21049	20869	22673	23762	23423	24837	26652	29007	32130	36742

Cipla Cash Flow

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Opening Cash & Cash Equivalents	176	546	858	610	853	508	649	790	658	561	512
Cash Flow from Operating Activities	1173	1741	2382	1463	1691	3068	3755	3326	3238	4134	5005
Cash Flow from Investing Activities	-941	-4523	-1310	-854	-1669	104	-2387	-1872	-2389	-2988	-3691
Cash Flow from Financing Activities	165	3104	-1326	-385	-349	-2949	-1240	-1600	-958	-1200	-1293
Net Cash Inflow / Outflow	397	322	-254	223	-326	224	129	-146	-109	-55	21
Closing Cash & Cash Equivalent	564	858	610	853	508	742	790	658	561	512	543

Cipla Ratios

#	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Earnings Per Share (Rs)	14.71	16.93	12.51	17.52	18.96	19.18	29.82	31.19	34.71	51.05	65.29
CEPS(Rs)	21.91	26.76	29.4	34.06	35.2	33.76	43.02	44.76	49.65	64.49	79.22
DPS(Rs)	2	2	2	3	3	4	5	5	8.5	13	16
Book NAV/Share(Rs)	133.38	142.23	155.15	175.92	185.62	194.85	226.73	257.78	289.24	329.72	384.84
Core EBITDA Margin(%)	18.87	17.98	16.92	18.57	12.95	11.72	15.05	15.18	16.13	17.76	19.24
EBIT Margin(%)	15.91	14.02	9.44	11.72	9.4	8.76	12.22	12.11	13.41	16.35	18.58
Pre Tax Margin(%)	14.44	12.52	8.35	10.97	8.7	8.03	11.66	11.75	13.05	16.1	18.42
PAT Margin (%)	10.95	10.12	7.13	9.33	6.31	5.7	8.51	8.61	9.17	11.73	14.29
Cash Profit Margin (%)	15.36	15.59	16.17	18.02	11.86	10.03	12.29	12.15	12.95	14.7	17.27
ROA(%)	7.85	7.28	4.97	6.52	6.5	6.56	9.95	9.94	10.19	13.59	15.36
ROE(%)	12.1	12.61	8.72	10.65	10.37	10.09	14.13	13.1	12.85	16.63	18.34
ROCE(%)	15.33	13.24	8.28	10.2	11.94	12.53	17.85	17.24	18.19	22.77	23.64
Receivable days	57.94	57.62	61.36	67.94	55.36	54.1	47.44	42.19	44.13	45.49	50.64
Inventory Days	106.36	100.43	90.98	90.29	61.13	56.12	58.49	61.53	61.98	53.56	53.61
Payable days	103.91	104.98	104.58	123.84	128.32	128.84	107.95	98.28	111.52	103.64	108.56
PER(x)	48.36	30.26	47.35	31.01	27.91	22.05	27.34	32.65	25.95	29.28	22.08
Price/Book(x)	5.33	3.6	3.82	3.09	2.85	2.17	3.6	3.95	3.11	4.53	3.75
Dividend Yield(%)	0.28	0.39	0.34	0.55	0.57	0.95	0.61	0.49	0.94	0.87	1.11
EV/Net Sales(x)	5.13	3.35	3.55	3.09	2.83	2.1	3.45	3.73	3.15	4.66	4.2
EV/Core EBITDA(x)	25.03	16.92	18.91	14.72	12.97	10.12	14.63	16.77	13.02	17.06	14.48
Net Sales Growth(%)	11.52	19.83	5.88	5.29	7.96	4.7	11.84	13.59	4.55	13.28	6.88
EBIT Growth(%)	-10.03	6.1	-28.55	29.11	26.01	5.69	45.26	4.31	15.23	39.63	18.84
PAT Growth(%)	-11.47	11.26	-25.3	36.16	6.36	2.48	55.23	6.59	10.78	46.55	27.33
EPS Growth(%)	-14.96	15.11	-26.1	40.05	8.23	1.16	55.46	4.61	11.28	47.06	27.89
Debt/Equity(x)	0.16	0.46	0.33	0.29	0.29	0.18	0.1	0.04	0.02	0.01	0
Current Ratio(x)	1.96	1.14	2.59	2.82	3.29	2.66	2.87	2.99	3.34	3.7	4.24
Quick Ratio(x)	0.99	0.65	1.56	1.77	2.24	1.67	1.85	1.91	2.31	2.7	3.21
Interest Cover(x)	10.83	9.36	8.67	15.61	13.34	12.04	21.47	33.85	37.87	64.44	111
Total Debt/Mcap(x)	0.03	0.13	0.09	0.09	0.1	0.08	0.03	0.01	0.01	0	0

Cipla Shareholding Pattern

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	33.41	33.41	33.4	33.4	33.4	33.4	30.86	30.86	29.13	29.13
FII	28.21	27.29	25.44	25.69	25.68	25.77	27.77	28.74	26.6	26.22
DII	20.96	21.96	24.22	24.06	24.22	24.3	24.84	24.04	27.59	28.09
Public	16.81	16.92	16.73	16.64	16.5	16.32	16.37	16.16	16.49	16.34
Others	0.61	0.42	0.2	0.21	0.21	0.21	0.16	0.21	0.2	0.22
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	26.96	26.96	26.96	26.96	26.96	26.96	24.92	24.92	23.53	23.53
FII	22.77	22.03	20.54	20.74	20.73	20.81	22.42	23.21	21.48	21.18
DII	16.92	17.72	19.55	19.43	19.55	19.62	20.06	19.41	22.28	22.69
Public	13.57	13.66	13.51	13.43	13.32	13.18	13.22	13.05	13.31	13.2
Others	0.49	0.34	0.16	0.17	0.17	0.17	0.13	0.17	0.16	0.17
Total	80.71	80.72	80.72	80.73	80.74	80.74	80.75	80.76	80.76	80.76

Pros

Company has delivered good profit growth of 27% CAGR over last 5 years
Company is almost debt free.

Cons

Promoter holding is low: 29.13%.
Debtor days have increased from 103.64 to 108.56days.
Stock is trading at 3.9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Cipla News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Cipla

Add Watchlist

Cipla Research see more...

Overview Inc. Year: 1935Industry: Pharmaceuticals & Drugs

Cipla Share Price

Alert Data

Quarterly Price

Peer Comparison

Cipla Quarterly Results

Cipla Profit & Loss

Growth Rates

Cipla Balance Sheet

Cipla Cash Flow

Cipla Ratios

Cipla Shareholding Pattern

Cipla News

IPO

Sharescart: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!

Enter Your Complaint